News >

Molecular Testing Advancements Leading Field of GI Cancers

Danielle Bucco
Published: Tuesday, Dec 26, 2017

 Shirley Michelle Shiller, DO

Shirley Michelle Shiller, DO
With the advent of next-generation sequencing and novel technologies, the understanding of the molecular alterations in gastrointestinal (GI) cancers has significantly improved.

on Gastrointestinal Cancers, Shiller, a pathologist at Baylor Scott and White Health, discussed progress with precision medicine for patients with gastrointestinal cancers.

OncLive: Please provide an overview of your presentation.

Shiller: I discussed the recent guidelines and recommendations, which were a collaborative effort between ASCO and various pathology organizations to ensure that we are streamlining testing.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™Aug 30, 20201.5
Publication Bottom Border
Border Publication